![Maria Ada Eufemia Forss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Ada Eufemia Forss
Director/Board Member at
Mabtech AB
Net worth: 141 980 $ as of 2026-08-30
Profile
Maria Ada Eufemia Forss is currently Director at Mabtech AB. Former positions include Chief Executive Officer at DuoCort Pharma AB, President & Chief Executive Officer at BICO Group AB from 2023 to 2026, Chairman at Bico International AB, Deputy Director at Laccure AB, Director at Oncorena AB and Oncorena Holding AB, Independent Director at LIDDS AB, VP-Business Development & Global Communications at Vitrolife AB from 2012 to 2023, Head-Business Development at Aqilion AB, and Principal at AstraZeneca A. Education includes undergraduate and MBA degrees from Concordia University and graduate studies at Handelshögskolan i Göteborg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-28 | 62,308 ( 0.09% ) | 141 980 $ | 2026-08-30 |
Maria Ada Eufemia Forss active positions
| Companies | Position | Start |
|---|---|---|
Mabtech AB
 Mabtech AB BiotechnologyHealth Technology Develops and sells tests & kits for studying immune responses though online | Director/Board Member | - |
Former positions of Maria Ada Eufemia Forss
| Companies | Position | End |
|---|---|---|
| BICO GROUP AB | Chief Executive Officer | 2026-08-30 |
| VITROLIFE AB | Public Communications Contact | - |
Bico International AB | Chairman | - |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Director/Board Member | - |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Corporate Officer/Principal | - |
Training of Maria Ada Eufemia Forss
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Vitrolife AB
 Vitrolife AB Medical SpecialtiesHealth Technology Develops, produces and markets products and systems for the preparation, cultivation and preservation of human cells, tissues and organs | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Finance |
Handelshögskolan i Göteborg
 Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca A/S (Denmark)
 AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Develops products for treatment of bacterial vaginosis in the field of skin care and hygiene activities | Health Technology |
DuoCort Pharma AB
 DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for glucocorticoid therapy | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Mabtech AB
Mabtech AB BiotechnologyHealth Technology Develops and sells tests & kits for studying immune responses though online | Health Technology |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
BICO Group AB
 BICO Group AB BiotechnologyHealth Technology Develops tools for bioprinting technology | Health Technology |
Bico International AB |
- Stock Market
- Insiders
- Maria Ada Eufemia Forss
